Moreira L F, Kamikawa Y, Naomoto Y, Haisa M, Orita K
First Department of Surgery, Okayama University Medical School, Japan.
Surg Laparosc Endosc. 1995 Jun;5(3):171-5.
Endoscopic mucosal resection (EMR) is a recently introduced therapeutic method based on the principles of the strip biopsy for resection of flat lesions of the gastrointestinal tract. Eleven asymptomatic patients (nine men, two women) with superficial carcinoma or high-grade dysplasia of the intrathoracic esophagus were treated by EMR during a 6-month period. The patients' mean age was 64 years (range, 49-78). The site of the lesions was the middle third of the esophagus in eight, upper third in two, and lower third in one patient. All patients in this series had a flat (II) type of superficial cancer. The procedure was carried out in all 11 patients without complication. Histopathological examination of the specimens revealed squamous cell carcinoma in nine patients. The remaining two patients were confirmed to have dysplasia only. Free margins measured greater than 5 mm in all cases. No recurrence was detected in a mean follow-up of 8 (5-10) months. For superficial flat lesions, EMR proved to be a safe and curative procedure that provided good quality of life following resection. However, larger trials are needed to confirm these results. Applying EMR to esophageal dysplasia could decrease the incidence of esophageal cancer.
内镜黏膜切除术(EMR)是一种基于条形活检原理新近引入的治疗方法,用于切除胃肠道扁平病变。在6个月的时间里,对11例无症状的胸段食管浅表癌或高级别异型增生患者(9例男性,2例女性)进行了内镜黏膜切除术治疗。患者的平均年龄为64岁(范围49 - 78岁)。病变部位位于食管中段的有8例,上段的有2例,下段的有1例。该系列所有患者均为扁平(II)型浅表癌。11例患者均顺利完成手术,无并发症发生。标本的组织病理学检查显示,9例患者为鳞状细胞癌。其余2例患者仅确诊为异型增生。所有病例切缘均大于5 mm。平均随访8(5 - 10)个月未发现复发。对于浅表扁平病变,内镜黏膜切除术被证明是一种安全有效的治疗方法,切除后能提供良好的生活质量。然而,需要更大规模的试验来证实这些结果。将内镜黏膜切除术应用于食管异型增生可降低食管癌的发病率。